BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 15451194)

  • 21. Trophoblastic lesions of the placental site.
    Baergen RN; Rutgers JL
    Gen Diagn Pathol; 1997 Nov; 143(2-3):143-58. PubMed ID: 9443571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors.
    Cole LA; Khanlian SA; Muller CY; Giddings A; Kohorn E; Berkowitz R
    Gynecol Oncol; 2006 Aug; 102(2):160-4. PubMed ID: 16631918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [MMP-2/TIMP-2 expression in the trophoblasts of patients with gestational trophoblastic disease].
    Ding F; Zhang QS; Xing FQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Feb; 27(2):150-2. PubMed ID: 17355922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical studies of trophoblastic tumors.
    Kalhor N; Ramirez PT; Deavers MT; Malpica A; Silva EG
    Am J Surg Pathol; 2009 Apr; 33(4):633-8. PubMed ID: 19145204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The role of KiSS-1 and matrix metalloproteinase-9 in regulation of invasion of trophoblasts].
    Qiao C; Cheng DL; Zhang SL; Wang CH; Lin QD
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):839-42. PubMed ID: 15949403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The c-erbB-related oncoproteins in normal placenta and in gestational trophoblastic diseases (in vitro study)].
    Fülöp V; Végh G; Doszpod J
    Orv Hetil; 2001 Jun; 142(22):1147-54. PubMed ID: 11424588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of maspin in gestational trophoblastic disease.
    Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
    Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical localization of inhibin-alpha in the placenta and gestational trophoblastic lesions.
    Shih IM; Kurman RJ
    Int J Gynecol Pathol; 1999 Apr; 18(2):144-50. PubMed ID: 10202672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P63 expression in gestational trophoblastic disease: correlation with proliferation and apoptotic dynamics.
    Zhang HJ; Xue WC; Siu MK; Liao XY; Ngan HY; Cheung AN
    Int J Gynecol Pathol; 2009 Mar; 28(2):172-8. PubMed ID: 19188816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Association of the novel hydatidiform mole-related gene F10 with the invasiveness of trophoblastic tumor].
    Zhou J; Chen SL; Xing FQ; Pang ZJ; Li B; Zhou WQ; Fu X; Ding YQ
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):171-3. PubMed ID: 15698997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HSD3B1 as a novel trophoblast-associated marker that assists in the differential diagnosis of trophoblastic tumors and tumorlike lesions.
    Mao TL; Kurman RJ; Jeng YM; Huang W; Shih IeM
    Am J Surg Pathol; 2008 Feb; 32(2):236-42. PubMed ID: 18223326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spontaneous regression in choriocarcinoma and related gestational trophobalstic neoplasms.
    Hertz R
    Natl Cancer Inst Monogr; 1976 Nov; 44():59-60. PubMed ID: 193022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of galectin-1, -3 (gal-1, gal-3) and the Thomsen-Friedenreich (TF) antigen in normal, IUGR, preeclamptic and HELLP placentas.
    Jeschke U; Mayr D; Schiessl B; Mylonas I; Schulze S; Kuhn C; Friese K; Walzel H
    Placenta; 2007; 28(11-12):1165-73. PubMed ID: 17664004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pathology of gestational trophoblastic disease: recent advances.
    Wells M
    Pathology; 2007 Feb; 39(1):88-96. PubMed ID: 17365825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of c-erb B-2 oncogene product in persistent gestational trophoblastic disease.
    Cameron B; Gown AM; Tamimi HK
    Am J Obstet Gynecol; 1994 Jun; 170(6):1616-21; discussion 1621-2. PubMed ID: 7911272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Placental site trophoblastic tumour: a case report.
    Hemalatha AL; Kumar DB; Sumanth D; Abhishek MG; Shashidhar HB
    Indian J Pathol Microbiol; 2007 Jul; 50(3):581-3. PubMed ID: 17883144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathology of gestational trophoblastic disease.
    Redline RW; Abdul-Karim FW
    Semin Oncol; 1995 Apr; 22(2):96-108. PubMed ID: 7740321
    [No Abstract]   [Full Text] [Related]  

  • 38. DOC-2/hDab2, a candidate tumor suppressor gene involved in the development of gestational trophoblastic diseases.
    Fulop V; Colitti CV; Genest D; Berkowitz RS; Yiu GK; Ng SW; Szepesi J; Mok SC
    Oncogene; 1998 Jul; 17(4):419-24. PubMed ID: 9696034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibiton of RET and JAK2 signals and upregulation of VEGFR3 phosphorylation in vitro by galectin-1 in trophoblast tumor cells BeWo.
    Fischer I; Schulze S; Kuhn C; Friese K; Walzel H; Markert UR; Jeschke U
    Placenta; 2009 Dec; 30(12):1078-82. PubMed ID: 19900702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gestational trophoblastic disease. New approaches to diagnosis.
    Lage JM; Wolf NG
    Clin Lab Med; 1995 Sep; 15(3):631-64. PubMed ID: 8542727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.